Drug
Factor IX clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 2
- first study started
- 2012
How studies write it
Studies that test it under each name
Name
Studies by the year they started
2 studies that test it; most in 2012 (1)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 3
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Tulane University (1) · Bioverativ Therapeutics Inc. (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Factor IX is read from its arms, and is right about nine times in ten.
Testing it · 3
- Factor IX as Adjunctive Therapy to Emicizumab (EMIX)CompletedEarly Phase 1Tulane UniversityNCT05281718Written as Factor IX
- Study of Recombinant Coagulation Factor IX Fc Fusion Protein, BIIB029, in Previously Treated Pediatric Participants With Hemophilia BCompletedPhase 3Bioverativ Therapeutics Inc.NCT01440946Written as FIX
- Cooperative Study of Factor VIII InhibitorsCompletedPhase 3National Heart, Lung, and Blood Institute (NHLBI)NCT00000582Written as factor ix
As the comparator · 1 — what is tested is compared with Factor IX
Codes
What other systems call Factor IX · ClinicalTrials.gg INT007468
- MeSH (NLM) D005164Factor IXOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D005164 | Factor IX | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.